Press releases
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 19, 2009
TAXUS® Element™ Drug-Eluting Stent is now available in select markets worldwide
-
May 19, 2009
Online tools will help physicians determine treatment strategies
-
May 15, 2009
A live webcast and replay of the May 22 conference will be available.
-
May 15, 2009
Presentations to include additional analyses from the landmark SYNTAX trial
-
May 14, 2009
ALTITUDE analysis presented at the Heart Rhythm Society Scientific Sessions
-
May 14, 2009
Analysis indicates that one life is now saved for every six patients who receive an ICD
-
May 13, 2009
Donation marks the beginning of Company's agreement to provide the non-profit organization with CRM devices that would otherwise remain unused
-
May 12, 2009
Company's new lead system reduces implant size of the world's smallest and thinnest high-energy devices
-
May 11, 2009
Authors identify important differences between drug-eluting stent brands
-
May 11, 2009
Highlights of the week's events include late-breaking trial presentations from the MADIT II clinical trial and the ALTITUDE Clinical Science Program